Divi’s Lab reports mute show for July-September quarter – what should investors do? ICICI Direct recommends THIS
According to ICICI Direct Research, the pharma major has reported in-line revenues with a significant miss on margins.
Divi’s Lab stock was top loser on Nifty index, it declined around 9 per cent to Rs 3,419 per share on the NSE: Pixabay